Get the Stockscreener App
29.06
0.45%
-0.13
After Hours:
29.49
0.43
+1.48%
Caredx Inc stock is traded at $29.06, with a volume of 723.62K.
It is down -0.45% in the last 24 hours and up +30.61% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$29.19
Open:
$29.15
24h Volume:
723.62K
Relative Volume:
0.91
Market Cap:
$1.50B
Revenue:
$412.82M
Net Income/Loss:
$-8.19M
P/E Ratio:
-188.58
EPS:
-0.1541
Net Cash Flow:
$64.17M
1W Performance:
-0.75%
1M Performance:
+30.61%
6M Performance:
+54.49%
1Y Performance:
+51.04%
1-Day Range:
$28.98
$29.88
1-Week Range:
$27.87
$30.00
52-Week Range:
$10.96
$30.00
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, NTRA, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
29.06 | 1.47B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
517.60 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.62 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.98 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
283.80 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
378.89 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
CareDx completes acquisition of Naveris - Investing.com
CareDx completes acquisition of Naveris By Investing.com - Investing.com Canada
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology - The Joplin Globe
Eurobio Scientific closes an acquisition - marketscreener.com
Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division - GlobeNewswire
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific - BioSpace
CareDx president and CEO John Hanna sells $1.17m stock By Investing.com - Investing.com South Africa
CareDx completes sale of lab products unit for $171.2M - Investing.com UK
CareDx president and CEO John Hanna sells $1.17m stock - Investing.com
Form 4 Caredx Inc For: 30 June By Investing.com - Investing.com Canada
CareDx (CDNA) CEO exercises 70k options, sells 40k shares under 10b5-1 plan - Stock Titan
CareDx completes sale of lab products unit for $171.2M By Investing.com - Investing.com Australia
CareDx Announces Dismissal of 2021 Qui Tam Suit - The National Law Review
Eurobio Scientific Société anonyme completed the acquisition of Caredx AB and Kitted Laboratory Products Business and Related Software of CareDx, Inc.. - marketscreener.com
CDNA: Insider Form 144 to sell 39,500 shares after option exercise (06/29/2026) - Stock Titan
Enterprise value to EBIT forward of CareDx, Inc. – NASDAQ:CDNA - TradingView
Caredx Inc stock hits 52-week high at $29.08 - Investing.com
Caredx Inc stock hits 52-week high at $29.08 By Investing.com - Investing.com Canada
Supreme Court Declines to Hear CareDx Appeal in Natera False-Advertising CaseHealthcare Earnings Report - dars.gov.et
1K9 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of CareDx, Inc. – BOATS:CDNA - TradingView
Price to earnings forward of CareDx, Inc. – BOATS:CDNA - TradingView
CDNA Forecast — Price Target — Prediction for 2027 - TradingView
CareDx, Inc. Actuals & Estimates (NASDAQ:CDNA) - TradingView
CareDx Inc (CDNA) Institutional Confidence - TradingKey
Caredx Inc stock hits 52-week high at 26.7 USD By Investing.com - Investing.com Australia
Caredx Inc stock hits 52-week high at 26.7 USD - Investing.com
CareDx's CEO Sells 17K Shares - Yahoo Finance
CareDx (CDNA) Stock Could Be 1.5% Overvalued After AlloSure Study Buzz - Sahm
Responsive Playbooks and the CDNA Inflection - Stock Traders Daily
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests - ChartMill
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? - Yahoo Finance
CareDx presents transplant monitoring data at medical congress - Investing.com UK
CareDx Inc (CDNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CareDx Inc (CDNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CareDx Inc (CDNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CareDx (CDNA) Showcases Innovations at American Transplant Congr - GuruFocus
CareDx Inc (CDNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
CareDx Inc (CDNA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CareDx presents transplant monitoring data at medical congress By Investing.com - Investing.com Nigeria
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress - Business Wire
How New AlloSure Kidney Prognostic Evidence At CareDx (CDNA) Has Changed Its Investment Story - Sahm
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx Inc (CDNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CareDx Inc (CDNA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CareDx Inc (CDNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CareDx (CDNA) CEO sells 17,683 shares under 10b5-1 plan - Stock Titan
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology - BioSpace
Insider Sell: Hannah Valantine Sells 12,103 Shares of CareDx Inc (CDNA) - GuruFocus
CareDx director Hannah Valantine sells $279,728 in stock By Investing.com - Investing.com India
CareDx director Hannah Valantine sells $279,728 in stock - Investing.com UK
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hanna John Walter JR | President and CEO |
Jun 15 '26 |
Option Exercise |
8.20 |
15,676 |
128,543 |
661,959 |
| Hanna John Walter JR | President and CEO |
Jun 11 '26 |
Option Exercise |
8.20 |
13,618 |
111,668 |
646,283 |
| Hanna John Walter JR | President and CEO |
Jun 04 '26 |
Option Exercise |
8.20 |
706 |
5,789 |
632,665 |
| Hanna John Walter JR | President and CEO |
Jun 26 '26 |
Option Exercise |
8.20 |
100 |
820 |
662,059 |
| Hanna John Walter JR | President and CEO |
Jun 29 '26 |
Sale |
29.24 |
39,900 |
1,166,836 |
661,959 |
| Hanna John Walter JR | President and CEO |
Jun 26 '26 |
Sale |
29.00 |
100 |
2,900 |
661,959 |
1.05%
2.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):